Labiotech.eu

News and Trends 29 Nov 2016

New British Partnership set to Cure Rare Diseases with Gene Therapy

Oxford BioMedica and Orchard Therapeutics are partnering up to bring gene therapy to the market and treat rare diseases for which no cure is available yet. Oxford BioMedica develops lentiviral vectors for gene and cell therapy applications. The company just announced a partnership with another biotech from the UK’s golden triangle, Orchard Therapeutics. The deal is […]

November 29, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 29 Nov 2016

The ABCs of ADCs: A Review of Antibody Drug Conjugates

Antibody therapies have a little sister who is catching up in funding – and hype? In light of now five deaths from Juno’s CAR-T therapy, antibody drug conjugates are attracting a lot of interest in a resurgence after their debut 10 years ago. To feel out the field, we talked to two CEOs competing directly […]

November 29, 2016 - 8 minutesmins - By Evelyn Warner

News and Trends 28 Nov 2016

Finally a Cure for the Common Cold? And it’s Needle-free!

Mucosis is starting Phase I trials for SynGEM, a needle-free vaccine against RSV, which causes 200k deaths per year and has a huge cost for both healthcare and the economy. Mucosis is a biotech from the Netherlands developing needle-free vaccines. The company has now initiated the first human trial for SynGEM, a nasal spray vaccine against […]

November 28, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Nov 2016

SynBio reinvents Photosynthesis with artificial CO2-fixing Pathway

Removing CO2 from the atmosphere could help with climate change, and there’s now a new biological method in the making to achieve this. Researchers have developed a new turbo-charged version of a metabolic pathway for fixing CO2, which is 20% more efficient than in plants. As described in an article just published in Science, a […]

November 28, 2016 - 3 minutesmins - By Denise Neves Gameiro

Interview 28 Nov 2016

Needle-Free Diabetes Monitoring: Interview with the Co-Founder of GlucoWise

The needle-free revolution for diabetes is coming! We interviewed Panos Kosmas, co-founder of MediWise, to get the juicy details of GlucoWise. This revolutionary wireless device could free the more than 422 million people living with diabetes worldwide from the daily pain of conventional glucose monitoring. Panos Kosmas is the co-founder and Chief Technical Officer of MediWise, a […]

November 28, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 26 Nov 2016

Fruit Flies are the Artists behind these Astounding Exhibitions

The Fly Printer by Laura Beloff transforms fruit flies into artists behind pieces that highlight the limits of always making humans the point of reference in technology. Fruit flies are a very common model organism for experimentation in biotech. Now, a piece of art at the Open Fields exhibition in Riga is inverting the roles […]

November 26, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 11 22 at 1.33.19 PM e1479818165882

News and Trends 25 Nov 2016

Structural Biology meets Drug Discovery in this Cool Company

After an amazing day in Paris for Labiotech Refresh, we head back to Germany to meet Proteros. The company is working non-stop to provide drug candidates against some of the hottest targets in biotech. City: Munich, Germany Founded: 1999 Employees: 80+ Financial data: The company just announced a €157M ($167M) deal with MSD Mission: Proteros’ expertise in structural biology […]

November 25, 2016 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 25 Nov 2016

Stories We Didn’t Cover: Malaria Vaccine Money, Diabetes FDA Approvals

Try as we might, we can’t cover all the biotech news out there. During the week, we only pick the top stories to keep you informed but not waste your time. Here’s a roundup of news that didn’t make the cut this week. WHO has injected €14M into GSK to advance its malaria vaccine. Umecrine Cognition, a […]

November 25, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 24 Nov 2016

A Finnish Company opens a New Avenue to Alternative Protein

How do you solve a problem like the viability of small-scale biogas production? Protein feed with a side of bioplastic, according to the Technical Research Centre of Finland. This emission-reducing process could not only yield interesting biobased products, but also solve some self-sufficiency and food security problems for Europe. Biogas is a promising biofuel, as it […]

November 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 24 Nov 2016

Infographic: The Changing Face of UK Drug Discovery by the Numbers

After Brexit, UK pharma is striving to reinvigorate drug discovery through collaboration. This infographic shows why that’s necessary. A new report from the Association of the British Pharmaceutical Industry (ABPI) has a grim finding: the UK is beginning to lose out on global drug discovery investment compared to 10 years ago. Spending on pharmaceutical R&D […]

November 24, 2016 - 1 minutemin - By Evelyn Warner

News and Trends 23 Nov 2016

This Company joins a Tech Initiative to Repair the Heart with Stem Cells

Eppendorf joins a Horizon 2020 consortium to support bioreactor development for stem cell cultivation for heart attack patients. Stem cells have huge potential to treat or even cure a wide variety of medical conditions. Efforts to mitigate damage after a heart attack with stem cells are making a lot of progress. Researchers have successfully grown […]

November 23, 2016 - 4 minutesmins - By External Contributor

News and Trends 23 Nov 2016

These Biotech Veterans have Launched a Startup to ‘Drug the Undruggable’

GPCRs have spelled “dead end” for many a biotech and academic endeavor. I sat down with Confo Therapeutics to hear about how they’re recruiting antibodies for a new onslaught. Despite their allure as the key to many indications, GPCRs are not a target for the faint of heart because they tend to move through a […]

November 23, 2016 - 4 minutesmins - By Evelyn Warner

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New British Partnership set to Cure Rare Diseases with Gene Therapy

The ABCs of ADCs: A Review of Antibody Drug Conjugates

Finally a Cure for the Common Cold? And it’s Needle-free!

SynBio reinvents Photosynthesis with artificial CO2-fixing Pathway

Needle-Free Diabetes Monitoring: Interview with the Co-Founder of GlucoWise

Fruit Flies are the Artists behind these Astounding Exhibitions

Structural Biology meets Drug Discovery in this Cool Company

Stories We Didn’t Cover: Malaria Vaccine Money, Diabetes FDA Approvals

A Finnish Company opens a New Avenue to Alternative Protein

Infographic: The Changing Face of UK Drug Discovery by the Numbers

This Company joins a Tech Initiative to Repair the Heart with Stem Cells

These Biotech Veterans have Launched a Startup to ‘Drug the Undruggable’

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!